Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?

Background: Direct-acting antiviral (DAA) agents for the treatment of hepatitis C virus (HCV) infection have been proven safe and effective in cirrhotic patients awaiting liver transplantation (LT). However, in the long term, data remain minimal regarding the clinical impact of viral eradication on...

Descripción completa

Detalles Bibliográficos
Autores principales: Meunier, Lucy, Belkacemi, Mohamed, Pageaux, George Philippe, Radenne, Sylvie, Vallet-Pichard, Anaïs, Houssel-Debry, Pauline, Duvoux, Christophe, Botta-Fridlund, Danielle, de Ledinghen, Victor, Conti, Filomena, Anty, Rodolphe, Di Martino, Vincent, Debette-Gratien, Marilyne, Leroy, Vincent, Gerster, Theophile, Lebray, Pascal, Alric, Laurent, Abergel, Armand, Dumortier, Jérôme, Besch, Camille, Montialoux, Helene, Samuel, Didier, Duclos-Vallée, Jean-Charles, Coilly, Audrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865729/
https://www.ncbi.nlm.nih.gov/pubmed/36680177
http://dx.doi.org/10.3390/v15010137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865729/
https://www.ncbi.nlm.nih.gov/pubmed/36680177
http://dx.doi.org/10.3390/v15010137

Ejemplares similares